Trulance (palbociclib) is not currently available as a generic medication [1]. It is a brand-name drug manufactured by Pfizer [2].
When Might Trulance Become Available as a Generic?
The patent expiration dates for Trulance are key to determining when generic versions could be introduced. According to DrugPatentWatch.com, various patents related to Trulance have expiration dates throughout the 2030s and beyond, depending on the specific patent and region [3]. This suggests that generic competition is not expected for several years.
What Is Trulance Used For?
Trulance is a medication used to treat certain types of breast cancer in adults. It is typically used in combination with an aromatase inhibitor or fulvestrant for postmenopausal women with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who have not had prior endocrine-based therapy [1].
How Does Trulance Work?
Trulance is a cyclin-dependent kinase (CDK) inhibitor. Specifically, it inhibits CDK4 and CDK6, which are proteins that play a role in cell division and growth. By blocking these kinases, Trulance helps to slow down or stop the growth of cancer cells [1].
What Are the Potential Side Effects of Trulance?
Common side effects associated with Trulance include low levels of white blood cells (neutropenia), fatigue, nausea, and diarrhea [1]. More serious side effects can also occur.
Are There Other Drugs Like Trulance?
Yes, there are other CDK4/6 inhibitors available for treating similar types of breast cancer. These include drugs like Ibrance (palbociclib), also manufactured by Pfizer, and Verzenio (abemaciclib) by Eli Lilly and Company [4, 5]. These medications share a similar mechanism of action but may have different side effect profiles and clinical data [4, 5].
Why Aren't There Generic Versions of Trulance Yet?
The primary reason for the absence of generic Trulance is the existing patent protection held by Pfizer. Patents grant the original manufacturer exclusive rights to sell the drug for a specific period, preventing others from producing generic versions until these patents expire or are successfully challenged [3].
What Happens When a Drug Becomes Generic?
Once a drug's patents expire and regulatory approval is granted, generic versions can be manufactured and sold. These generic drugs are required to have the same active ingredient, dosage form, strength, route of administration, and intended use as the brand-name drug. They must also demonstrate bioequivalence, meaning they work the same way in the body. The introduction of generics typically leads to a significant decrease in the drug's price [6].
Sources
1. https://www.trulance.com/
2. https://www.pfizer.com/products/product-detail/trulance
3. https://drugpatentwatch.com/
4. https://www.ibrance.com/
5. https://www.verzenio.com/
6. https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs